SYON CAPITAL LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1999353
SAN FRANCISCO, CA
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$804,424
+$206,884 QoQ
Shares Held
3,547
+2.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#256
of 564 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SYON CAPITAL LLC holds $11,119,149 across 14 Diagnostics & Research names. CRL ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,474 | $1,741,724 | |
| 2 | ILMN |
Illumina, Inc.
|
8,606 | $1,513,192 | |
| 3 | DHR |
Danaher Corp /De/
|
6,884 | $1,311,264 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,668 | $878,101 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
3,547 | $804,424 | |
| 6 | A |
Agilent Technologies, Inc.
|
5,976 | $793,792 | |
| 7 | DGX |
Quest Diagnostics Inc
|
3,595 | $761,960 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3,518 | $679,747 |
All Filings in CRL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $804,424 | 3,547 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $597,540 | 3,464 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $764,207 | 3,831 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $689,988 | 4,410 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $327,433 | 2,158 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $254,077 | 1,688 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||